唐人神(002567.SZ):6月生豬銷售收入同比升81.3% 環比降10.7%
格隆匯 7 月 7日丨唐人神(002567.SZ)宣佈,唐人神集團股份有限公司(以下簡稱“公司”)2020年6月生豬銷量5.81萬頭,同比下降25.5%,環比上升10.2%;銷售收入合計16,248萬元,同比上升81.3%,環比下降10.7%。2020年1-6月累計商品豬銷量28.03萬頭,同比下降44.9%;銷售收入92,309萬元,同比上升76.2%。
公司2020年6月生豬銷售收入同比上升主要原因是生豬價格同比去年大幅上漲;2020年6月公司生豬銷量同比下降的主要原因是前期加大仔豬銷售以及本期加大種豬選留。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.